Trial
NCT01085656
A Phase I Clinical Trial of OXi4503 for Relapsed and Refractory AML and MDS
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Florida
Collaborators
The Leukemia and Lymphoma Society
Condition
Leukemia, Myelogenous, Acute
Intervention
OXi4503
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-08-08